# ZULRESSO
> **NDA211371** · New Drug Application · Sponsor: SAGE THERAP · Approved 2019-03-19
## Drug
- **FDA Application Number:** NDA211371
- **Application type:** New Drug Application
- **Brand name:** ZULRESSO
- **Generic name:** Brexanolone
- **Active ingredients:** BREXANOLONE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** SAGE THERAP
- **First approval:** 2019-03-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211371)
---
*AI Analytics · CC0 1.0*